- Original research
- Open Access
Associations of therapeutic hypothermia with clinical outcomes in patients receiving ECPR after cardiac arrest: systematic review with meta-analysis
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine volume 28, Article number: 3 (2020)
Therapeutic hypothermia has been recommended for eligible patients after cardiac arrest (CA) in order to improve outcomes. Up to now, several comparative observational studies have evaluated the combined use of extracorporeal cardiopulmonary resuscitation (ECPR) and therapeutic hypothermia in adult patients with CA. However, the effects of therapeutic hypothermia in adult CA patients receiving ECPR are inconsistent.
Relevant studies in English databases (PubMed, ISI web of science, OVID, and Embase) were systematically searched up to September 2019. Odds ratios (ORs) from eligible studies were extracted and pooled to summarize the associations of therapeutic hypothermia with favorable neurological outcomes and survival in adult CA patients receiving ECPR.
13 articles were included in the present meta-analysis study. There were nine studies with a total of 806 cases reporting the association of therapeutic hypothermia with neurological outcomes in CA patients receiving ECPR. Pooling analysis suggested that therapeutic hypothermia was significantly associated with favorable neurological outcomes in overall (N = 9, OR = 3.507, 95%CI = 2.194–5.607, P < 0.001, fixed-effects model) and in all subgroups according to control type, regions, sample size, CA location, ORs obtained methods, follow-up period, and modified Newcastle Ottawa Scale (mNOS) scores. There were nine studies with a total of 806 cases assessing the association of therapeutic hypothermia with survival in CA patients receiving ECPR. After pooling the ORs, therapeutic hypothermia was found to be significantly associated with survival in overall (N = 9, OR = 2.540, 95%CI = 1.245–5.180, P = 0.010, random-effects model) and in some subgroups. Publication bias was found when evaluating the association of therapeutic hypothermia with neurological outcomes in CA patients receiving ECPR. Additional trim-and-fill analysis estimated four “missing” studies, which adjusted the effect size to 2.800 (95%CI = 1.842–4.526, P < 0.001, fixed-effects model) for neurological outcomes.
Therapeutic hypothermia may be associated with favorable neurological outcomes and survival in adult CA patients undergoing ECPR. However, the result should be treated carefully because it is a synthesis of low-level evidence and other limitations exist in present study. It is necessary to perform randomized controlled trials to validate our result before considering the result in clinical practices.
Cardiac arrest (CA) remains the leading cause of sudden death and is associated with high mortality despite much progress in advanced life support [1,2,3,4,5,6]. Cardiopulmonary resuscitation using extracorporeal membrane oxygenation (ECPR), also called extracorporeal life support (ECLS), is a modified form of cardiopulmonary bypass. As an alternative resuscitation method, it facilitates the establishment of normal circulation, provides adequate organ perfusion, and then improves both neurological outcomes and survival following CA . Compared with conventional cardiopulmonary resuscitation (CCPR), ECPR is associated with 13% absolute increase of 30 days survival rate in both out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) [7,8,9,10,11,12]. Technological improvements have made it more accessible and its use has been increased over the past decades, especially in patients with refractory CA [13, 14]. According to the American Heart Association 2015 Guidelines, ECPR may be considered for selected CA patients with potentially reversible etiology .
Despite ECPR, the survival rate at hospital discharge with favorable neurological outcomes remains low in CA patients [16,17,18]. Targeted temperature management (TTM) or mild therapeutic hypothermia via surface cooling has been showed to improve survival and neurological outcomes in patients resuscitated from CA [19, 20]. Cooling the body to 32–34 °C leads to a relative 35% increase in survival compared with no intervention . International guidelines strongly recommend initiating therapeutic hypothermia for eligible CA patients to improve outcomes [22,23,24]. ECPR is an ideal tool for rapid and homogenous cooling and can also be augmented with surface cooling. Up to now, there are some studies evaluating the combined use of ECPR and therapeutic hypothermia in adult CA patients and/or comparing therapeutic hypothermia treatment with no therapeutic hypothermia induction [9, 25,26,27,28,29,30,31,32,33,34,35,36,37]. However, the sample size of those studies is limited, the proportion of patients receiving therapeutic hypothermia ranges variously, and no conclusive result is derived whether there is a benefit of therapeutic hypothermia treatment in CA patients undergoing ECPR.
In the present study, for the first time, we performed a systematic review with meta-analysis to compare neurological outcomes and survival (Outcomes) between therapeutic hypothermia treatment at 32–34 °C (Intervention) and any other temperature controls including no therapeutic hypothermia induction and alternative targeted temperatures range (> 34 °C, ≤36 °C) (Control) in adult CA patients receiving ECPR (Population).
Materials and methods
The results of this meta-analysis were written according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) reporting guidelines for randomized trials and MOOSE (Meta-analysis Of Observational Studies in Epidemiology) reporting guidelines for observational studies. We used the PICO (Participants/Population, Intervention/Exposure, Comparison/Control, and Outcomes) scheme to generate the research questions, create a search strategy, and guide study selection. Participants/Population, adult CA patients undergoing ECPR; no restrictions were applied to downtime, bystander CPR attempt, or witnessed arrest. Intervention/Exposure, therapeutic hypothermia with a targeted temperature of 32–34 °C. Comparison/Control, any temperature controls (> 34 °C) including no therapeutic hypothermia induction and alternative targeted temperatures range (> 34 °C, ≤36 °C). Outcomes,  favorable neurological outcome at hospital discharge/30 days/90 days, which were evaluated by the cerebral performance category (CPC) with CPC1–2 as favorable outcomes ; survival at hospital discharge/30 days/90 days.
A systematic search of relevant articles on the associations of therapeutic hypothermia with clinical outcomes (survival or neurological outcomes) in CA patients undergoing ECPR published from January 2000 to September 2019 was carried out in four English databases (PubMed, OVID, Embase, and ISI Web of Science). The following searching keywords were used, “extracorporeal membrane oxygenation OR extracorporeal oxygenation OR extracorporeal circulation OR extracorporeal cardiopulmonary resuscitation OR extracorporeal life support OR ECMO OR ECPR OR E-CPR OR ECLS”, “out-of-hospital cardiac arrest OR in-hospital cardiac arrest OR cardiac arrest OR heart arrest OR OHCA OR IHCA”, and “Hypothermia OR therapeutic hypothermia OR induced hypothermia OR mild hypothermia OR cooling OR cryotherapy OR targeted temperature management OR TTM”. The retrieved articles were screened and selected according to the inclusion and exclusion criteria by two independent investigators. The references of the selected articles and the review articles were also screened to identify additional eligible studies.
Inclusion and exclusion criteria
Inclusion criteria,  subjects were adult patients with CA undergoing ECPR ; the clinical outcomes reported in the studies were neurological outcomes (primary outcomes) and patients’ survival (secondary outcomes) at hospital discharge/30 days/90 days; the neurological outcomes should be assessed by Cerebral Performance Categories (CPC) score and CPC 1 or 2 was defined as favorable outcomes while CPC 3–5 were defined as poor outcomes  ; the target temperature of therapeutic hypothermia was stated ; the clinical outcomes between therapeutic hypothermia intervention and controls were compared ; unadjusted or adjusted odds ratios (ORs) with their 95% confidence intervals reflecting the associations of therapeutic hypothermia with clinical outcomes were reported or the proportions of the patients with unfavorable and favorable outcomes in therapeutic hypothermia and control arms were reported ; the language was limited as English. Exclusion criteria,  studies included other disease besides CA and the results for CA could not be separated ; studies performed in neonates/children/pediatric patients ; studies included other treatments besides ECPR (such as CCPR) and results for ECPR could not be separated ; studies with insufficient data ; studies with sample size< 10 ; studies with duplicate data; the author information, study centers, population, and the results of the candidate studies were compared to identify the studies with fully or partly duplicate data; when studies with duplicate data were identified, the studies with larger sample size and more recently published were included ; all patients were treated with therapeutic hypothermia (i.e. no controls) ; the target temperature of therapeutic hypothermia was not reported ; not original full articles, such as abstracts, letters, or review articles; and  case series or case report.
The following information was collected by two authors independently at the same time from each eligible study, the author information, publication year, countries, study period, gender, age, sample size, location of CA, bystander CPR attempt, rhythm, follow-up points, outcomes, indication criteria of ECPR and therapeutic hypothermia, target temperature of therapeutic hypothermia and control arms, the comparability of baseline characteristics, CA characteristics and neurological status before therapeutic hypothermia treatment, patients number with unfavorable/favorable outcomes in therapeutic hypothermia and control arms or direct ORs with 95%CIs, and analysis method (univariate or multivariate analysis). We also tried to contact with the authors of the included studies for detailed results needed in our study. Disagreement was solved by discussion and if the disagreement was still not solved, the arbitration would be performed by a third author.
Quality score assessment
The methodological quality of each included article was evaluated by a modified Newcastle Ottawa Scale (mNOS) with scores ranging from 0 to 9 (Additional file 1: Table S1). mNOS score ≥ 7 was considered as high quality.
The odds ratios (ORs) with 95% CIs from each eligible study were pooled to assess the strength of the associations of therapeutic hypothermia with neurological outcomes or survival in adult CA patients undergoing ECPR. If 30 days endpoints were not reported, discharge endpoints were used. The longest available follow-up endpoints were used in overall analysis and all follow-up endpoints were used when performing subgroup analysis according to follow-up period. The association was considered significant if P < 0.05 by Z-test. Chi-square based on Q statistic test was used to quantify the heterogeneity in each analysis. If P>0.1/I2<50%, ORs were pooled with fixed-effects model (Mantel-Haenszel method); otherwise, the random-effects model (DerSimonian-Laird method) was used . Begg’s funnel plots and Egger’s test were used to determine the potential publication bias [40, 41]. The Duval and Tweedie’s trim-and-fill method, a funnel plot-derived and two-step method, was used to estimate the effect size accounting for publication bias. The stability of the pooling result was verified by sensitivity analysis through omitting each study in each turn. In addition, subgroup analyses according to control type, regions, sample size, CA location, ORs obtained methods, follow-up period, and mNOS scores were also performed. Stata 12.0 software (Stata Corp, College Station, TX, USA) was used to perform all the analyses.
Identification of studies
Figure 1 showed the literature searching and screening process. According to the searching strategy, a total of 3792 documents were initially retrieved from four English databases (PubMed, OVID, Embase and ISI Web of Science) and additional sources. After excluding the duplicated papers, review or meeting abstracts, and irrelevant articles, 60 articles were left for further screening by checking the full texts. 47 articles were excluded, of which, seven were overlapped studies [42,43,44,45,46,47,48], seven were performed in pediatric patients [49,50,51,52,53,54,55], two study contained patients with other disease besides CA and the data related to CA could not be obtained separately [16, 56], three studies contained CA patients treated with other methods besides ECPR and the data related to ECPR could not be obtained separately [17, 57, 58], fifteen studies had no sufficient data [59,60,61,62,63,64,65,66,67,68,69,70,71,72,73], and eleven studies only had therapeutic hypothermia arms (without controls) [37, 74,75,76,77,78,79,80,81,82,83]. Two studies did not state the specific temperature of therapeutic hypothermia and control arms [84, 85]. Finally, 13 papers containing 1159 cases were included in the present study [9, 25,26,27,28,29,30,31,32,33,34,35,36]. Notably, two papers published by Kagawa et al. in 2012 and 2015 with some overlapped participants were both included because they reported different clinical outcomes [25, 27]. Studies by Kim et al. in 2014  and Han et al. in 2019  also had overlapped participants, however, the article in 2019 only reported patients’ survival, thus the article in 2014 was included when analyzing neurological outcomes. Goto et al.  and Otani et al.  performed studies on partly overlapped population. Goto et al. collected the patients from 2005 to 2013 and reported both neurological and survival outcomes while Otani et al. collected the patients from 2009 to 2017 and reported only neurological outcomes. Thus, the study by Goto et al. was included when analyzing patients’ survival whereas the study by Otani et al. was included when analyzing patients’ neurological outcomes according to inclusion and exclusion criteria.
The detailed characteristics of the included 13 articles were shown in Table 1 and Additional file 2: Table S2. The studies were published from 2012 to 2019 and the samples size ranged from 10 to 274. The studies were conducted in Korea (n = 5), Japan (n = 6), Australia (n = 1), and Singapore (n = 1). The proportion of patients receiving therapeutic hypothermia, with favorable neurological outcomes, and with survival ranged from 13.14 to 78.26%, 13.92 to 35.14%, and 14.00 to 43.48%, respectively. Seven studies enrolled only OHCA patients and six studies enrolled both IHCA and OHCA patients. Nine studies reported the association of therapeutic hypothermia with neurological outcomes in adults CA patients undergoing ECPR [9, 26,27,28, 30,31,32, 34, 36], and nine reported the association of therapeutic hypothermia with patients’ survival [9, 25, 28,29,30,31, 33, 35, 36]. Quality assessment was performed according to a modified NOS (Additional file 1: Table S1). The mNOS scores ranged from 6 to 9 for neurological outcomes (Additional file 1: Table S3) and from 6 to 8 for survival outcomes (Additional file 1: Table S4).
Association of therapeutic hypothermia with neurological outcomes in CA patients receiving ECPR
There were nine studies with a total of 806 cases reporting the association of therapeutic hypothermia with neurological outcomes in CA patients receiving ECPR. Six studies reporting neurological outcomes at hospital discharge and three studies reporting that at 90 days. Pooling analysis suggested that therapeutic hypothermia was significantly associated with favorable neurological outcomes in CA patients receiving ECPR in overall (N = 9, OR = 3.507, 95%CI = 2.194–5.607, P < 0.001, fixed-effects model) and in all subgroups according to control type, regions, sample size, CA location, ORs obtained methods, follow-up period, and mNOS scores (Fig. 2a and Table 2).
Association of therapeutic hypothermia with survival in CA patients receiving ECPR
There were nine studies with a total of 806 cases assessing the association of therapeutic hypothermia with survival in CA patients receiving ECPR. After pooling the ORs, therapeutic hypothermia was found to be significantly associated with favorable survival in overall (N = 9, OR = 2.540, 95%CI = 1.245–5.180, P = 0.010, random-effects model; Fig. 2b and Table 3). After subgroup analysis according to control type, regions, sample size, CA location, ORs obtained methods, follow-up period, and mNOS scores, significant associations were found in subgroups of other temperature control (N = 5, P = 0.039, random-effects model), larger sample size (N = 5, P = 0.010, random-effects model), mixed CA location (N = 4, P = 0.048, fixed-effects model), OHCA (N = 5, P = 0.050, random-effects model), univariate analysis obtained ORs (N = 8, P = 0.025, random-effects model), 30 days/at discharge survival (N = 8, P = 0.023, random-effects model), and high mNOS scores (N = 4, P < 0.001, fixed-effects model).
Heterogeneity, sensitivity analysis and publication bias
No heterogeneity existed when assessing the association of therapeutic hypothermia with neurological outcome while heterogeneity was found when evaluating the association of therapeutic hypothermia with patients’ survival. After deleting the studies by Kagawa et al. in 2012 and Lee et al. in 2016, the heterogeneity reduced to insignificance and the association of therapeutic hypothermia with patients’ survival was still significant (N = 7, OR = 3.410, 95%CI = 2.168–5.362, P < 0.001, fixed-effects model). Sensitivity analysis was performed to examine the influence of individual study on the pooling ORs and revealed almost the same results (Fig. 3a and b). Begg’s and Egger’s tests were used to assess the publication bias. Publication bias was found when evaluating the association of therapeutic hypothermia with neurological outcomes (Fig. 4a and Table 2; Pbegg = 0.048, Pegger = 0.008). Trim-and-fill analysis suggested that there were four “missing” studies on the bottom side of the funnel plot (Fig. 4b). After adjustment, therapeutic hypothermia was still significantly associated with favorable neurological outcomes in CA patients receiving ECPR (OR = 2.800, 95%CI = 1.842–4.526, P < 0.001, fixed-effects model). Conversely, no publication bias was found when evaluating the association of therapeutic hypothermia with patients’ survival (Fig. 4c and Table 3; Pbegg = 0.754, Pegger = 0.703).
Therapeutic hypothermia can decrease cerebral metabolism, alleviate the ischemic loss of ion gradients, reduce free radicals, and decrease postischemic inflammation after cerebral ischemia, thus protect patients against hypoxic brain damage following CA [86, 87]. Therapeutic hypothermia has been recommended for eligible CA patients in order to improve outcomes and is increasingly used [22,23,24]. However, whether it improves neurological outcomes and survival in ECPR treated CA patients is not conclusive and the results in recent research are not consistent. In addition, therapeutic hypothermia can bring significant major complications including coagulation dysfunction, infection, and other systemic problems . This promoted us, for the first time, to perform a systematic review with meta-analysis to summarize the effects of therapeutic hypothermia in CA patients receiving ECPR, and we found therapeutic hypothermia might be associated with favorable neurological outcomes and survival in CA patients receiving ECPR in overall.
Therapeutic hypothermia is intended to be performed in CA patients with poor neurological status. Of the 13 included studies, seven studies describe the indications of therapeutic hypothermia treatments [9, 25, 27, 29, 31, 34, 36]. All the unconscious patients after ECPR are recommended receiving therapeutic hypothermia in six studies and one study  randomly divides the unconscious CA patients into therapeutic hypothermia group and non-therapeutic hypothermia group. In other words, the patients in therapeutic hypothermia arms usually have a poorer neurological status at baseline than those in control arms, which might act as a bias when evaluating the associations of therapeutic hypothermia with patients’ outcomes. We pooled the seven studies and found that therapeutic hypothermia was associated with patients’ favorable neurological outcomes (N = 4, OR = 3.627, 95%CI = 1.533–8.468, P = 0.003, fixed-effects model) and survival (N = 4, OR = 3.248, 95%CI = 1.909–5.525, P < 0.001, fixed-effects model), indicating that although the patients in therapeutic hypothermia arm might have a poorer baseline neurological status, an improved prognosis was still identified.
In 2002, two randomized clinical trials (RCTs) suggest that therapeutic hypothermia at 33 °C improves patients’ neurological outcomes compared to any temperature controls in CA [19, 89]. Recently, Nielsen et al. perform a large RCT and find no differences of patients’ neurological outcomes and survival between target temperature managements at 33 °C and 36 °C . However, it is difficult to extrapolate this result to the ECPR population. In 2015, Kagawa et al. perform an observational study on 237 patients receiving targeted temperature management after CA and find no difference of neurological outcomes between targeted temperatures management at < 34 °C and at ≥34 °C in entire CA patients . Nevertheless, they find < 34 °C is associated with improved neurological outcomes in combined ECPR treated CA patients. In the present study, we observed improved neurological outcomes after therapeutic hypothermia induction at ≤34 °C compared to no therapeutic hypothermia induction (N = 4, OR = 4.794, 95%CI = 2.037–11.28, P < 0.001, fixed-effects model) or alternative targeted temperature controls (> 34 °C) (N = 5, OR = 3.067, 95%CI = 1.750–5.374, P < 0.001, fixed-effects model), respectively, in CA patients undergoing ECPR.
Therapeutic hypothermia is associated with OHCA patients compared with IHCA patients in practice . In the 13 included studies, the proportion of patients receiving therapeutic hypothermia ranges from 20.74 to 78.26% with an average of 41.13% in studies enrolling only OHCA patients and from 13.14 to 55.17% with an average of 25.79% in studies enrolling both IHCA and OHCA patients. And in patients receiving therapeutic hypothermia, the proportion of those with favorable neurological outcomes ranges from 13.92 to 30.00% with an average of 15.80% in studies enrolling only OHCA patients and from 19.54 to 35.13% with an average of 26.00% in studies enrolling both IHCA and OHCA patients. Similar results are also observed in the studies in which all CA patients received therapeutic hypothermia and ECPR [30, 37, 74,75,76,77,78,79,80,81,82]. As OHCA is associated with worse outcomes compared to IHCA [45, 62, 91], the proportion of OHCA patients in studies enrolling both OHCA and IHCA patients may influence the analysis of the associations of therapeutic hypothermia with neurological outcomes and survival in CA patients undergoing ECPR. The pooling ORs for neurological outcomes in subgroup enrolling only OHCA and subgroup enrolling both OHCA and IHCA are 5.320 and 2.828, respectively. The pooling ORs for patients’ survival in subgroup enrolling only OHCA and subgroup enrolling both OHCA and IHCA are 3.759 and 1.703, respectively.
Selection criteria for starting ECPR and characteristics of CA including cause of CA may also affect our results stability. Almost of our enrolled studies have stated the ECPR inclusion and exclusion criteria (Additional file 2: Table S2), however, these criteria are diverse, and we can’t solve this problem based on current data. Characteristic of CA, such as the proportion of the patients with IHCA, witnessed CA, bystander CPR attempt, shockable rhythm, cardiac origin CA, or acute coronary syndrome, are also different in our enrolled studies (Additional file 2: Table S2). We have used a meta-regression method to explore the effects of the characteristic of CA on the association of therapeutic hypothermia with neurological outcomes in CA patients receiving ECPR and find these characteristics have no effect on their association (Additional file 1: Table S5).
There are other shortcomings that may impact our results stability. Firstly, the eligible studies and sample size are relative limited although we try our best to search all the potential eligible studies. Secondly, all the eligible studies are retrospective observational studies and most of them do not compare the baseline characteristics, CA characteristics, and initial neurological status before therapeutic hypothermia treatment. Thirdly, most of the included studies have not reported adjusted ORs. Finally, the eligible studies are conducted in only several regions including Korea, Japan, Singapore, and Australia. Thus, further prospective well-designed and multicentric random controlled studies with larger sample size should be conducted to validate our conclusions.
We got a comprehensive result from the current meta-analysis that therapeutic hypothermia might be associated with favorable neurological outcomes and survival in adult patients undergoing ECPR after cardiac arrest. However, our result is a synthesis of retrospective observational studies, which are the low-level evidence, and should be treated carefully. Further prospective well-designed and multicentric randomized controlled trials with larger sample size are necessary before putting our result into clinical practices.
Availability of data and materials
All data generated or analyzed during this study are included in the published article that listed in Table 1.
95% confidence interval
Conventional cardiopulmonary resuscitation
Cerebral Performance Categories
Extracorporeal life support
Extracorporeal cardiopulmonary resuscitation
In-hospital cardiac arrest
Lower 95% confidence interval
Modified Newcastle Ottawa Scale (mNOS)
Out-of-hospital cardiac arrest
- Pbegg :
P-value for Begg’s test
- Pegger :
P-value for Egger’s test
- Phetero :
P-value for heterogeneity
Targeted temperature management
Upper 95% confidence interval
Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circ. 2001;104(18):2158–63.
Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham heart study. Circ. 2004;110(5):522–7.
Girotra S, van Diepen S, Nallamothu BK, Carrel M, Vellano K, Anderson ML, et al. Regional variation in out-of-hospital cardiac arrest survival in the United States. Circ. 2016;133(22):2159–68.
Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM, Chan PS, et al. Trends in survival after in-hospital cardiac arrest. N Engl J Med. 2012;367(20):1912–20.
Goldberger ZD, Chan PS, Berg RA, Kronick SL, Cooke CR, Lu M, et al. Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet. 2012;380(9852):1473–81.
Pozzi M, Koffel C, Armoiry X, Pavlakovic I, Neidecker J, Prieur C, et al. Extracorporeal life support for refractory out-of-hospital cardiac arrest: should we still fight for? A single-Centre, 5-year experience. Int J Cardiol. 2016;204:70–6.
Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008;372(9638):554–61.
Ha TS, Yang JH, Cho YH, Chung CR, Park CM, Jeon K, et al. Clinical outcomes after rescue extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest. Emerg Med J. 2017;34(2):107–11.
Maekawa K, Tanno K, Hase M, Mori K, Asai Y. Extracorporeal cardiopulmonary resuscitation for patients with out-of-hospital cardiac arrest of cardiac origin: a propensity-matched study and predictor analysis. Crit Care Med. 2013;41(5):1186–96.
Kim SJ, Kim HJ, Lee HY, Ahn HS, Lee SW. Comparing extracorporeal cardiopulmonary resuscitation with conventional cardiopulmonary resuscitation: a meta-analysis. Resuscitation. 2016;103:106–16.
Blumenstein J, Leick J, Liebetrau C, Kempfert J, Gaede L, Gross S, et al. Extracorporeal life support in cardiovascular patients with observed refractory in-hospital cardiac arrest is associated with favourable short and long-term outcomes: a propensity-matched analysis. Eur Heart J Acute Cardiovasc Care. 2016;5(7):13–22.
Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engstrom AE, Lagrand WK, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med. 2016;42(12):1922–34.
Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014;64(14):1407–15.
Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med. 2016;42(5):889–96.
Brooks SC, Anderson ML, Bruder E, Daya MR, Gaffney A, Otto CW, et al. Part 6: alternative techniques and ancillary devices for cardiopulmonary resuscitation: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circ. 2015;132(18 Suppl 2):S436–43.
Bednarczyk JM, White CW, Ducas RA, Golian M, Nepomuceno R, Hiebert B, et al. Resuscitative extracorporeal membrane oxygenation for in hospital cardiac arrest: a Canadian observational experience. Resuscitation. 2014;85(12):1713–9.
Siao FY, Chiu CC, Chiu CW, Chen YC, Chen YL, Hsieh YK, et al. Managing cardiac arrest with refractory ventricular fibrillation in the emergency department: conventional cardiopulmonary resuscitation versus extracorporeal cardiopulmonary resuscitation. Resuscitation. 2015;92:70–6.
Sakamoto S, Taniguchi N, Nakajima S, Takahashi A. Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome. Ann Thorac Surg. 2012;94(1):1–7.
Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557–63.
Hypothermia after Cardiac Arrest Study G. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–56.
Arrich J, Holzer M, Havel C, Mullner M, Herkner H. Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev. 2016;2:CD004128.
Howes D, Gray SH, Brooks SC, Boyd JG, Djogovic D, Golan E, et al. Canadian guidelines for the use of targeted temperature management (therapeutic hypothermia) after cardiac arrest: a joint statement from the Canadian critical care society (CCCS), Canadian Neurocritical care society (CNCCS), and the Canadian critical care trials group (CCCTG). Resuscitation. 2016;98:48–63.
Nikolaou NI, Arntz HR, Bellou A, Beygui F, Bossaert LL, Cariou A, et al. European resuscitation council guidelines for resuscitation 2015 section 8. Initial Manage Acute Coron Syndr Resuscitation. 2015;95:264–77.
Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VR, Deakin CD, et al. European resuscitation council and European Society of Intensive Care Medicine Guidelines for post-resuscitation care 2015: section 5 of the European resuscitation council guidelines for resuscitation 2015. Resuscitation. 2015;95:202–22.
Kagawa E, Dote K, Kato M, Sasaki S, Nakano Y, Kajikawa M, et al. Should we emergently Revascularize occluded coronaries for cardiac arrest? Rapid-response extracorporeal membrane oxygenation and intra-arrest percutaneous coronary intervention. Circ. 2012;126(13):1605–13.
Kim SJ, Jung JS, Park JH, Park JS, Hong YS, Lee SW. An optimal transition time to extracorporeal cardiopulmonary resuscitation for predicting good neurological outcome in patients with out-of-hospital cardiac arrest: a propensity-matched study. Critical Care. 2014;18(5).
Kagawa E, Dote K, Kato M, Sasaki S, Oda N, Nakano Y, et al. Do lower target temperatures or prolonged cooling provide improved outcomes for comatose survivors of cardiac arrest treated with hypothermia? J Am Heart Assoc. 2015;4(9).
Choi DH, Kim YJ, Ryoo SM, Sohn CH, Ahn S, Seo DW, et al. Extracorporeal cardiopulmonary resuscitation among patients with out-of-hospital cardiac arrest. Clin Exp Emerg Med. 2016;3(3):132–8.
Lee JJ, Han SJ, Kim HS, Hong KS, Choi HH, Park KT, et al. Out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal membrane oxygenation: focus on survival rate and neurologic outcome. Scand J Trauma Resuscitation Emerg Med. 2016;24.
Dennis M, McCanny P, D'Souza M, Forrest P, Burns B, Lowe DA, et al. Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: a multicentre experience. Int J Cardiol. 2017;231:131–6.
Pang PYK, Wee GHL, Huang MJ, Hoo AEE, Sheriff IMT, Lim SL, et al. Therapeutic hypothermia may improve neurological outcomes in extracorporeal life support for adult cardiac arrest. Heart Lung Circ. 2017;26(8):817–24.
Yukawa T, Kashiura M, Sugiyama K, Tanabe T, Hamabe Y. Neurological outcomes and duration from cardiac arrest to the initiation of extracorporeal membrane oxygenation in patients with out-of-hospital cardiac arrest: a retrospective study. Scand J Trauma Resusc Emerg Med. 2017;25(1):95.
Goto T, Morita S, Kitamura T, Natsukawa T, Sawano H, Hayashi Y, et al. Impact of extracorporeal cardiopulmonary resuscitation on outcomes of elderly patients who had out-of-hospital cardiac arrests: a single-Centre retrospective analysis. BMJ Open. 2018;8(5):e019811.
Otani T, Sawano H, Natsukawa T, Nakashima T, Oku H, Gon C, et al. Low-flow time is associated with a favorable neurological outcome in out-of-hospital cardiac arrest patients resuscitated with extracorporeal cardiopulmonary resuscitation. J Crit Care. 2018;48:15–20.
Han KS, Kim SJ, Lee EJ, Jung JS, Park JH, Lee SW. Experience of extracorporeal cardiopulmonary resuscitation in a refractory cardiac arrest patient at the emergency department. Clin Cardiol. 2019;42(4):459–66.
Ryu JA, Chung CR, Cho YH, Sung K, Jeon K, Suh GY, et al. Neurologic outcomes in patients who undergo extracorporeal cardiopulmonary resuscitation. Ann Thorac Surg. 2019;108(3):749–55.
Stub D, Bernard S, Pellegrino V, Smith K, Walker T, Sheldrake J, et al. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation. 2015;86:88–94.
Prohl J, Rother J, Kluge S, de Heer G, Liepert J, Bodenburg S, et al. Prediction of short-term and long-term outcomes after cardiac arrest: a prospective multivariate approach combining biochemical, clinical, electrophysiological, and neuropsychological investigations. Crit Care Med. 2007;35(5):1230–7.
D R, L N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629–34.
Pang PY, Wee GH, Hoo AE, Sheriff IM, Lim SL, Tan TE, et al. Therapeutic hypothermia in adult patients receiving extracorporeal life support: early results of a randomized controlled study. J Cardiothorac Surg. 2016;11:43.
Ryu JA, Cho YH, Sung K, Choi SH, Yang JH, Choi JH, et al. Predictors of neurological outcomes after successful extracorporeal cardiopulmonary resuscitation. BMC Anesthesiol. 2015;15.
Ryu JA, Lee YH, Chung CR, Cho YH, Sung K, Jeon K, et al. Prognostic value of computed tomography score in patients after extracorporeal cardiopulmonary resuscitation. Crit Care. 2018;22(1):323.
Kagawa E, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Kurisu S, et al. Assessment of outcomes and differences between in- and out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal life support. Resuscitation. 2010;81(8):968–73.
Kim YS, Cho YH, Sung K, Ryu JA, Chung CR, Suh GY, et al. Target Temperature Management May Not Improve Clinical Outcomes of Extracorporeal Cardiopulmonary Resuscitation. J Intensive Care Med. 2019;34(10):790–6.
Lee SW, Han KS, Park JS, Lee JS, Kim SJ. Prognostic indicators of survival and survival prediction model following extracorporeal cardiopulmonary resuscitation in patients with sudden refractory cardiac arrest. Ann Intensive Care. 2017;7(1):87.
Kim Y, Ryu J-A, Kim YO, Cho YH, Yang JH, Lee S, et al. Prognostic value of optic nerve sheath diameter in patients after extracorporeal cardiopulmonary resuscitation. J Neurointensive Care. 2019;2(1):17–24.
Cheng HH, Rajagopal SK, Sansevere AJ, McDavitt E, Wigmore D, Mecklosky J, et al. Post-arrest therapeutic hypothermia in pediatric patients with congenital heart disease. Resuscitation. 2018;126:83–9.
Meert KL, Guerguerian AM, Barbaro R, Slomine BS, Christensen JR, Berger J, et al. Extracorporeal cardiopulmonary resuscitation: one-year survival and neurobehavioral outcome among infants and children with in-hospital cardiac arrest. Crit Care Med. 2018;12:12.
Torres-Andres F, Fink EL, Bell MJ, Sharma MS, Yablonsky EJ, Sanchez-De-Toledo J. Survival and long-term functional outcomes for children with cardiac arrest treated with extracorporeal cardiopulmonary resuscitation. Pediatr Crit Care Med. 2018;19(5):451–8.
Doherty DR, Parshuram CS, Gaboury I, Hoskote A, Lacroix J, Tucci M, et al. Hypothermia therapy after pediatric cardiac arrest. Circ. 2009;119(11):1492–U57.
Huang SC, Wu ET, Chen YS, Chang CI, Chiu IS, Wang SS, et al. Extracorporeal membrane oxygenation rescue for cardiopulmonary resuscitation in pediatric patients. Crit Care Med. 2008;36(5):1607–13.
Topjian AA, Telford R, Holubkov R, Nadkarni VM, Berg RA, Dean JM, et al. The association of early post-resuscitation hypotension with discharge survival following targeted temperature management for pediatric in-hospital cardiac arrest. Resuscitation. 2019;141:24–34.
Cuevas Guaman M, Lucke AM, Hagan JL, Kaiser JR. Bleeding complications and mortality in neonates receiving therapeutic hypothermia and extracorporeal membrane oxygenation. Am J Perinatol. 2018;35(3):271–6.
Bouglé A, Le Gall A, Dumas F, Geri G, Malissin I, Voicu S, et al. ExtraCorporeal life support for cardiac ARrest in patients with post cardiac arrest syndrome: the ECCAR study. Arch Cardiovasc Dis. 2019;112(4):253–60.
Avalli L, Mauri T, Citerio G, Migliari M, Coppo A, Caresani M, et al. New treatment bundles improve survival in out-of-hospital cardiac arrest patients: a historical comparison. Resuscitation. 2014;85(9):1240–4.
Nagao K, Hayashi N, Kanmatsuse K, Arima K, Ohtsuki J, Kikushima K, et al. Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol. 2000;36(3):776–83.
Sharma AS, Pijls RW, Weerwind PW, Delnoij TS, de Jong WC, Gorgels AP, et al. Out-of-hospital cardiac arrest: the prospect of E-CPR in the Maastricht region. Neth Hear J. 2016;24(2):120–6.
Reynolds JC, Grunau BE, Elmer J, Rittenberger JC, Sawyer KN, Kurz MC, et al. Prevalence, natural history, and time-dependent outcomes of a multi-center north American cohort of out-of-hospital cardiac arrest extracorporeal CPR candidates. Resuscitation. 2017;117:24–31.
Wang CH, Chou NK, Becker LB, Lin JW, Yu HY, Chi NH, et al. Improved outcome of extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest--a comparison with that for extracorporeal rescue for in-hospital cardiac arrest. Resuscitation. 2014;85(9):1219–24.
Avalli L, Maggioni E, Formica F, Redaelli G, Migliari M, Scanziani M, et al. Favourable survival of in-hospital compared to out-of-hospital refractory cardiac arrest patients treated with extracorporeal membrane oxygenation: An Italian tertiary care Centre experience. Resuscitation. 2012;83(5):579–83.
Fagnoul D, Taccone FS, Belhaj A, Rondelet B, Argacha JF, Vincent JL, et al. Extracorporeal life support associated with hypothermia and normoxemia in refractory cardiac arrest. Resuscitation. 2013;84(11):1519–24.
Sakamoto T, Morimura N, Nagao K, Asai Y, Yokota H, Nara S, et al. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study. Resuscitation. 2014;85(6):762–8.
Stub D, Nehme Z, Bernard S, Lijovic M, Kaye DM, Smith K. Exploring which patients without return of spontaneous circulation following ventricular fibrillation out-of-hospital cardiac arrest should be transported to hospital? Resuscitation. 2014;85(3):326–31.
Ryu JA, Park TK, Chung CR, Cho YH, Sung K, Suh GY, et al. Association between Body Temperature Patterns and Neurological Outcomes after Extracorporeal Cardiopulmonary Resuscitation. Plos One. 2017;12(1).
Liem S, Cavarocchi NC, Hirose H. Comparing in-patient extracorporeal cardiopulmonary resuscitation to standard cardiac treatment group of extracorporeal membrane oxygenation patients: 8 years of experience at a single institution. Perfusion,267659119860735 (2019).
Lamhaut L, Tea V, Raphalen JH, An K, Dagron C, Jouffroy R, et al. Coronary lesions in refractory out of hospital cardiac arrest (OHCA) treated by extra corporeal pulmonary resuscitation (ECPR). Resuscitation. 2018;126:154–9.
Nakashima T, Noguchi T, Tahara Y, Nishimura K, Ogata S, Yasuda S, et al. Patients with refractory out-of-cardiac arrest and sustained ventricular fibrillation as candidates for extracorporeal cardiopulmonary resuscitation ― prospective multi-center observational study ―. Circ J. 2019;83(5):1011–8.
Bhardwaj A, Miano T, Geller B, Milewski RC, Williams M, Bermudez C, et al. Venovenous extracorporeal membrane oxygenation for patients with return of spontaneous circulation after cardiac arrest owing to acute respiratory distress syndrome. J Cardiothorac Vasc Anesth. 2019;33(8):2216–20.
Kaushal M, Schwartz J, Gupta N, Im J, Leff J, Jakobleff WA, et al. Patient demographics and extracorporeal membranous oxygenation (ECMO)-related complications associated with survival to discharge or 30-day survival in adult patients receiving Venoarterial (VA) and Venovenous (VV) ECMO in a quaternary care Urban Center. J Cardiothorac Vasc Anesth. 2019;33(4):910–7.
Park JH, Song KJ, Shin SD, Ro YS, Hong KJ. Time from arrest to extracorporeal cardiopulmonary resuscitation and survival after out-of-hospital cardiac arrest. Emerg Med Australas. 2019.
Zakhary B, Nanjayya VB, Sheldrake J, Collins K, Ihle JF, Pellegrino V. Predictors of mortality after extracorporeal cardiopulmonary resuscitation. Crit Care Resusc. 2018;20(3):223–30.
Nagao K, Kikushima K, Watanabe K, Tachibana E, Tominaga Y, Tada K, et al. Early induction of hypothermia during cardiac arrest improves neurological outcomes in patients with out-of-hospital cardiac arrest who undergo emergency cardiopulmonary bypass and percutaneous coronary intervention. Circ J. 2010;74(1):77–85.
Leick J, Liebetrau C, Szardien S, Fischer-Rasokat U, Willmer M, van Linden A, et al. Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest. Clin Res Cardiol. 2013;102(9):661–9.
Deye N, Cariou A, Girardie P, Pichon N, Megarbane B, Midez P, et al. Endovascular versus external targeted temperature Management for Patients with out-of-Hospital Cardiac Arrest a Randomized, controlled study. Circ. 2015;132(3):182–93.
Peigh G, Cavarocchi N, Hirose H. Saving life and brain with extracorporeal cardiopulmonary resuscitation: a single-center analysis of in-hospital cardiac arrests. J Thorac Cardiovasc Surg. 2015;150(5):1344–9.
Lee YH, Oh YT, Ahn HC, Kim HS, Han SJ, Lee JJ, et al. The prognostic value of the grey-to-white matter ratio in cardiac arrest patients treated with extracorporeal membrane oxygenation. Resuscitation. 2016;99:50–5.
Tagami T, Matsui H, Kuno M, Moroe Y, Kaneko J, Unemoto K, et al. Early antibiotics administration during targeted temperature management after out-of-hospital cardiac arrest: a nationwide database study. Bmc Anesthesiol. 2016;16.
Kim YS, Lee YJ, Won KB, Kim JW, Lee SC, Park CR, et al. Extracorporeal cardiopulmonary resuscitation with therapeutic hypothermia for prolonged refractory in-hospital cardiac arrest. Korean Circ J. 2017;47(6):939–48.
Bartos JA, Carlson K, Carlson C, Raveendran G, John R, Aufderheide TP, et al. Surviving refractory out-of-hospital ventricular fibrillation cardiac arrest: critical care and extracorporeal membrane oxygenation management. Resuscitation. 2018;132:47–55.
Chouihed T, Kimmoun A, Lauvray A, Laithier FX, Jaeger D, Lemoine S, et al. Improving patient selection for refractory out of hospital cardiac arrest treated with extracorporeal LIFE support. Shock. 2018;49(1):24–8.
Jung C, Bueter S, Wernly B, Masyuk M, Saeed D, Albert A, et al. Lactate clearance predicts good neurological outcomes in cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation. J Clin Med. 2019;8(3):374.
Komeyama S, Takagi K, Tsuboi H, Tsuboi S, Morita Y, Yoshida R, et al. The early initiation of extracorporeal life support may improve the neurological outcome in adults with cardiac arrest due to cardiac events. Intern Med. 2019;58(10):1391–7.
Axtell AL, Funamoto M, Legassey AG, Moonsamy P, Shelton K, DA D’A, et al. Predictors of Neurologic Recovery in Patients who undergo Extracorporeal Membrane Oxygenation for Refractory Cardiac Arrest. J Cardiothorac Vasc Anesth. 2019.
Froehler MT, Geocadin RG. Hypothermia for neuroprotection after cardiac arrest: mechanisms, clinical trials and patient care. J Neurol Sci. 2007;261(1–2):118–26.
Gunn AJ, Thoresen M. Hypothermic neuroprotection. NeuroRx. 2006;3(2):154–69.
Soleimanpour H, Rahmani F, Golzari SE, Safari S. Main complications of mild induced hypothermia after cardiac arrest: a review article. J Cardiovasc Thorac Res. 2014;6(1):1–8.
Group HaCAS. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–56.
Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013;369(23):2197–206.
Haneya A, Philipp A, Diez C, Schopka S, Bein T, Zimmermann M, et al. A 5-year experience with cardiopulmonary resuscitation using extracorporeal life support in non-postcardiotomy patients with cardiac arrest. Resuscitation. 2012;83(11):1331–7.
We thank Kunihiko Maekawa (Sapporo Medical University School of Medicine, Sapporo, Japan) for providing related unpublished results for our study.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Modified Newcastle-Ottawa scale (mNOS) used in present study for cohort studies. Table S3. Modified Newcastle-Ottawa scale (mNOS) scores of our included studies for neurological outcomes. Table S4. Modified Newcastle-Ottawa scale (mNOS) scores of our included studies for patients’ survival. Table S5. Meta-regression analyses on characteristics of cardiac arrest for the associations of therapeutic hypothermia with favorable neurological outcomes in CA patients receiving ECPR.
Detailed characteristics of the included studies.
About this article
Cite this article
Chen, X., Zhen, Z., Na, J. et al. Associations of therapeutic hypothermia with clinical outcomes in patients receiving ECPR after cardiac arrest: systematic review with meta-analysis. Scand J Trauma Resusc Emerg Med 28, 3 (2020). https://doi.org/10.1186/s13049-019-0698-z
- Therapeutic hypothermia
- Cardiac arrest
- Neurological outcomes
- Extracorporeal cardiopulmonary resuscitation